Brief Review Open Access August 19, 2022

COVID-19 and Central Nervous System Diseases

Jiaxia Li 1, Yuan Feng 1, Mingwu Xia 1 and Li Wan 2, 3,*
1
The Second People's Hospital of Hefei; Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230011, China
2
Affiliated Psychological Hospital of Anhui Medical University; Hefei Fourth People's Hospital; Anhui Mental Health Center, Anhui 230026, China
3
Anhui Branch of National Clinical Research Center for Mental Disorders, Anhui 230026, China;Anhui Clinical Research Center for Mental Disorders, Anhui 230026, China
Page(s): 9-13
Received
July 10, 2022
Revised
August 09, 2022
Accepted
August 17, 2022
Published
August 19, 2022
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2022. Published by Scientific Publications
Article metrics
Views
1680
Downloads
2861

Cite This Article

APA Style
Li, J. , Li, J. Feng, Y. , Feng, Y. Xia, M. , & Xia, M. (2022). COVID-19 and Central Nervous System Diseases. Current Research in Public Health, 1(1), 9-13. https://doi.org/10.31586/wjcmr.2022.386
ACS Style
Li, J. ; Li, J. Feng, Y. ; Feng, Y. Xia, M. ; Xia, M. COVID-19 and Central Nervous System Diseases. Current Research in Public Health 2022 1(1), 9-13. https://doi.org/10.31586/wjcmr.2022.386
Chicago/Turabian Style
Li, Jiaxia, Jiaxia Li. Yuan Feng, Yuan Feng. Mingwu Xia, and Mingwu Xia. 2022. "COVID-19 and Central Nervous System Diseases". Current Research in Public Health 1, no. 1: 9-13. https://doi.org/10.31586/wjcmr.2022.386
AMA Style
Li J, Li JFeng Y, Feng YXia M, Xia M. COVID-19 and Central Nervous System Diseases. Current Research in Public Health. 2022; 1(1):9-13. https://doi.org/10.31586/wjcmr.2022.386
@Article{crph386,
AUTHOR = {Li, Jiaxia and Feng, Yuan and Xia, Mingwu and Wan, Li},
TITLE = {COVID-19 and Central Nervous System Diseases},
JOURNAL = {Current Research in Public Health},
VOLUME = {1},
YEAR = {2022},
NUMBER = {1},
PAGES = {9-13},
URL = {https://www.scipublications.com/journal/index.php/WJCMR/article/view/386},
ISSN = {2831-5162},
DOI = {10.31586/wjcmr.2022.386},
ABSTRACT = {We reviewed the influence of coronavirus disease 2019 (COVID-19) on the central nervous system reported in the literature since its prevalence. Common neurological symptoms of COVID-19 include altered or impaired consciousness, headache, dizziness, cerebrovascular accidents, and seizures, etc. Encephalopathy caused by or related to COVID-19 includes stroke, acute encephalitis, and Guillain-Barre syndrome. Concomitant COVID-19 in patients with vascular risk factors increased the risk of stroke; the hypercoagulable state and vascular dysfunction caused by COVID-19 also led to stroke. Acute encephalitis was usually accompanied by a history of headache, fever, and altered mental status, and shown hemorrhagic lesions or high signal on MRI. In Guillain-Barre syndrome, there was a time lag between infection with the primary pathogen and the onset of neurological symptoms, which generally manifest as limb paralysis and various sensory abnormalities. The review illustrated that COVID-19 lead to serious consequences of brain and brought difficulties to the treatment. Exploring the neural mechanisms of COVID-19 to better understand the activity of the virus in the brain and to prevent further viral damage to the brain is an urgent issue.},
}
%0 Journal Article
%A Li, Jiaxia
%A Feng, Yuan
%A Xia, Mingwu
%A Wan, Li
%D 2022
%J Current Research in Public Health

%@ 2831-5162
%V 1
%N 1
%P 9-13

%T COVID-19 and Central Nervous System Diseases
%M doi:10.31586/wjcmr.2022.386
%U https://www.scipublications.com/journal/index.php/WJCMR/article/view/386
TY  - JOUR
AU  - Li, Jiaxia
AU  - Feng, Yuan
AU  - Xia, Mingwu
AU  - Wan, Li
TI  - COVID-19 and Central Nervous System Diseases
T2  - Current Research in Public Health
PY  - 2022
VL  - 1
IS  - 1
SN  - 2831-5162
SP  - 9
EP  - 13
UR  - https://www.scipublications.com/journal/index.php/WJCMR/article/view/386
AB  - We reviewed the influence of coronavirus disease 2019 (COVID-19) on the central nervous system reported in the literature since its prevalence. Common neurological symptoms of COVID-19 include altered or impaired consciousness, headache, dizziness, cerebrovascular accidents, and seizures, etc. Encephalopathy caused by or related to COVID-19 includes stroke, acute encephalitis, and Guillain-Barre syndrome. Concomitant COVID-19 in patients with vascular risk factors increased the risk of stroke; the hypercoagulable state and vascular dysfunction caused by COVID-19 also led to stroke. Acute encephalitis was usually accompanied by a history of headache, fever, and altered mental status, and shown hemorrhagic lesions or high signal on MRI. In Guillain-Barre syndrome, there was a time lag between infection with the primary pathogen and the onset of neurological symptoms, which generally manifest as limb paralysis and various sensory abnormalities. The review illustrated that COVID-19 lead to serious consequences of brain and brought difficulties to the treatment. Exploring the neural mechanisms of COVID-19 to better understand the activity of the virus in the brain and to prevent further viral damage to the brain is an urgent issue.
DO  - COVID-19 and Central Nervous System Diseases
TI  - 10.31586/wjcmr.2022.386
ER  -